Education Library

Resources for Health Care Professionals

Filter Results

Condition

Audience

Topic

Type

SmartAssist® Technology LV Metrics FAQs

Jo Kajewski, advanced Impella® trainer, answers some frequently asked questions about LV metrics displayed using Impella SmartAssist technology.

Troubleshooting Suspected Hemolysis in Patients Supported with Impella® Heart Pump

Jessica Page, global Impella trainer, reviews the clinical signs and symptoms of hemolysis and provides tips for reducing the risk of hemolysis in patients supported with the Impella heart pump.

Impella® with SmartAssist® Technology: Deriving the LV Waveform and Measuring LVEDP

Jo Kajewski, advanced Impella trainer, describes how the LV waveform is derived and how LVEDP is measured using Impella with SmartAssist technology.

Weaning with the SmartAssist® Technology Trend Screen

Jessica Page, advanced Impella® trainer, reviews how to use the SmartAssist trend screen during weaning of Impella.

A Story of Significant EF Improvement with Biventricular Impella® Support

To the surprise of all the treating cardiologists, the patient presented with an ejection fraction of 5%, which improved to 55% on Day 6 after support with Impella RP® and Impella CP®.

What is the Difference Between “Venting” and “Unloading”?

Navin Kapur, MD, succinctly explains the concept of ventricular unloading.

Study Finds pVADs are Cost-Effective for High-Risk PCI

In the era of increasing healthcare costs, the cost-effectiveness of traditional versus emerging technologies is an ongoing consideration when evaluating long-term outcomes.

Automated Impella Controller™ (AIC): Understanding and Navigating the Placement Screen

Jo Kajewski, global Impella® trainer, describes the soft buttons, waveforms, and other information displayed on the AIC placement screen when a patient is on Impella support. 

Assessing and Maintaining the Impella® Access Site

Jo Kajewski, advanced Impella trainer, discusses how to assess the Impella access site, change dressings, and help prevent access site bleeding to improve patient outcomes. 

Amin et al. 

This FAQ explains how the conclusion of Amin et al. conflicts with more robust, previously published, FDA-audited, peer-reviewed, real-world studies and RCTs.

Dhruva et al. 

This FAQ explains how the conclusions of Dhruva et al. conflict with Impella® best practice outcomes reported in more robust, previously published, contemporary, prospective studies.

Information for Physicians: Medical Office Review of Dhruva et al.

Seth Bilazarian, MD, identifies and discusses a number of limitations of the Dhurva et al. paper.

FAQ: Is There Randomized Controlled Trial Data Available for Impella® Heart Pump Use in Cardiogenic Shock?

This FAQ discusses the challenges of obtaining RCT data for cardiogenic shock and presents the clinical data that is currently available and ongoing.

Managing Impella® Position Using Imaging and the Automated Impella Controller™

Jo Kajewski, advanced Impella trainer, discusses how Impella should appear on baseline echo and steps for repositioning Impella if a positioning alarm occur. 

Calculating Total Heparin Rate

Learn how to account for Impella® delivered heparin when calculating the total heparin dose for a patient supported with an Impella heart pump. 

NPS-1674

This information is intended for use by customers, patients, and healthcare professionals in [region] only. We recognize that the Internet is a global communications medium; however, laws, regulatory requirements, and product information for medical products can vary from country to country. The product information included here may not be appropriate for use outside [region], and the information from other sites you visit may not be appropriate for use in [region].